Comparison of Two Commercial Colorimetric Broth Microdilution Tests for <i>Candida</i> Susceptibility Testing: Sensititre YeastOne versus MICRONAUT-AM

Comparison of Two Commercial Colorimetric Broth Microdilution Tests for <i>Candida</i> Susceptibility Testing: Sensititre YeastOne versus MICRONAUT-AM

Two colorimetric broth microdilution antifungal susceptibility tests were compared, Sensititre YeastOne and MICRONAUT-AM for nine antifungal agents. One hundred clinical <i>Candida</i> isolates were tested, representing a realistic population for susceptibility testing in daily practice....

Full description

Bibliographic Details
Main Authors:	Sophie Philips, Frederik Van Hoecke, Emmanuel De Laere, Steven Vervaeke, Roos De Smedt, Jerina Boelens, Deborah De Geyter, Denis Piérard, Katrien Lagrou
Format:	Article
Language:	English
Published:	MDPI AG 2021-05-01
Series:	Journal of Fungi
Subjects:	<i>Candida</i> antifungal agents antifungal susceptibility testing colorimetry CLSI EUCAST
Online Access:	https://www.mdpi.com/2309-608X/7/5/356

Similar Items

Estudo comparativo entre as metodologias preconizadas pelo CLSI e pelo EUCAST para avaliação da atividade antifúngica Comparative study of the recommended methodologies by CLSI and EUCAST for activity evaluation antifungal
by: Marcos Aurélio Stoppa, et al.
Published: (2009-01-01)

Antimicrobial activity of manogepix, a first-in-class antifungal, and comparator agents tested against contemporary invasive fungal isolates from an international surveillance programme (2018–2019)
by: Michael A. Pfaller, et al.
Published: (2021-09-01)

Changes in the interpretation of the results of susceptibility testing of fungi
by: Rok Tomazin, et al.
Published: (2014-05-01)

Susceptibility Testing of Fungi to Antifungal Drugs
by: Maurizio Sanguinetti, et al.
Published: (2018-09-01)

Use of the VITEK 2 system to identify and test the antifungal susceptibility of clinically relevant yeast species
by: MSC Melhem, et al.
Published: (2013-12-01)

Antifungal susceptibility testing of Aspergillus species complex in the Clinical Laboratory: how to do it, when to do it, and how to interpret it
by: Esther Manso, et al.
Published: (2014-12-01)

Antifungal susceptibility testing of Candida in the Clinical Laboratory: how to do it, when to do it, and how to interpret it
by: Esther Manso, et al.
Published: (2014-06-01)

Pefloxacin as a Surrogate Marker for Fluoroquinolone Susceptibility for Salmonella typhi: Problems and Prospects
by: Balaji Veeraraghavan, et al.
Published: (2016-08-01)

In Vitro Azole and Amphotericin B Susceptibilities of <i>Malassezia furfur</i> from Bloodstream Infections Using E-Test and CLSI Broth Microdilution Methods
by: Wafa Rhimi, et al.
Published: (2020-06-01)

Comparative Analysis of Disc Diffusion and E-test with Broth Micro-dilution for Susceptibility Testing of Clinical Candida Isolates Against Amphotericin B, Fluconazole, Voriconazole and Caspofungin
by: Deepak Kumar, et al.
Published: (2015-11-01)

Antifungal Susceptibility Testing of Fusarium: A Practical Approach
by: Abdullah M. S. Al-Hatmi, et al.
Published: (2017-04-01)

Susceptibility testing of Leishmania spp. against amphotericin B and fluconazole using the Sensititre™ YeastOne™ YO9 platform
by: Ruwandi Kariyawasam, et al.
Published: (2019-07-01)

In Vitro Activity of Ibrexafungerp against a Collection of Clinical Isolates of <i>Aspergillus</i>, Including Cryptic Species and Cyp51A Mutants, Using EUCAST and CLSI Methodologies
by: Olga Rivero-Menendez, et al.
Published: (2021-03-01)

Updated EUCAST Clinical Breakpoints against <i>Aspergillus</i>, Implications for the Clinical Microbiology Laboratory
by: Jesús Guinea
Published: (2020-12-01)

Estudio comparativo de medición entre lecturas visuales y espectrofotométricas en pruebas de susceptibilidad in vitro de aislamientos de candida Comparative study of measure visual and spectrophotometer lectures in a in vitro antifungal susceptibility testing in candida isolates
by: Luis Enrique Jerez Puebla, et al.
Published: (2011-06-01)

Antifungal susceptibility profile of Trichosporon isolates: correlation between CLSI and etest methodologies
by: Raquel M.L. Lemes, et al.
Published: (2010-06-01)

SUSCEPTIBILITY OF Candida spp. ISOLATED FROM BLOOD CULTURES AS EVALUATED USING THE M27-A3 AND NEW M27-S4 APPROVED BREAKPOINTS
by: Edileusa Rosa dos Santos, et al.
Published: (2014-12-01)

<i>Fusarium musae</i> from Diseased Bananas and Human Patients: Susceptibility to Fungicides Used in Clinical and Agricultural Settings
by: Valeria Tava, et al.
Published: (2021-09-01)

Comparison of the ATB® Fungus 2 with the AFST-EUCAST for in vitro susceptibility testing of Candida spp
by: Jehidys Estella Montiel Ramos, et al.
Published: (2014-04-01)

Comparison of the VITEK 2 Yeast Antifungal Susceptibility Testing with CLSI Broth Microdilution Reference Method for Testing Four Antifungal Drugs against Candida species Isolated from Blood Samples
by: Vijaya S. Rajmane, et al.
Published: (2018-01-01)

Candida albicans and Candida dubliniensis Show Different Trailing Effect Patterns When Exposed to Echinocandins and Azoles
by: Rania Ayadi, et al.
Published: (2020-06-01)

An Outbreak of <i>Trichophyton quinckeanum</i> Zoonotic Infections in the Czech Republic Transmitted from Cats and Dogs
by: Pavlína Lysková, et al.
Published: (2021-08-01)

Dermatophyte susceptibilities to antifungal azole agents tested in vitro by broth macro and microdilution methods Suscetibilidade in vitro de dermatófitos a azóis pelos métodos macro e microdiluição em caldo
by: Emerson Roberto Siqueira, et al.
Published: (2008-02-01)

Microdilution procedure for antifungal susceptibility testing of Paracoccidioides brasiliensis to amphotericin b and itraconazole
by: E Takahagi-Nakaira, et al.
Published: (2009-01-01)

Correlation between microdilution, Etest, and disk diffusion methods for antifungal susceptibility testing of fluconazole against Candida sp. blood isolates
by: Everardo Albuquerque Menezes, et al.
Published: (2013-01-01)

Antifungal susceptibility testing for yeasts: how, when and why, according to the new EUCAST guidelines
by: Esther Manso, et al.
Published: (2011-03-01)

Comparison between E-test and CLSI broth microdilution method for antifungal susceptibility testing of Candida albicans oral isolates Comparação entre E-test e o método da microdiluição do CLSI para teste de susceptibilidade a antifúngicos de isolados orais de Candida albicans
by: Cristiane Yumi Koga-Ito, et al.
Published: (2008-02-01)

Comparison of Four Methods for the in vitro Susceptibility Testing of Dermatophytes
by: Anthi-Marina Markantonatou, et al.
Published: (2020-07-01)

Identification and Testing of Antidermatophytic Oxaborole-6-Benzene Sulphonamide Derivative (OXBS) from <i>Streptomyces atrovirens </i>KM192347 Isolated from Soil<i> </i>
by: Seham Abdel-Shafi, et al.
Published: (2020-04-01)

Antifungal Resistance: Specific Focus on Multidrug Resistance in <i>Candida auris</i> and Secondary Azole Resistance in <i>Aspergillus fumigatus</i>
by: Sevtap Arikan-Akdagli, et al.
Published: (2018-12-01)

Linking Cellular Morphogenesis with Antifungal Treatment and Susceptibility in <i>Candida</i> Pathogens
by: Jehoshua Sharma, et al.
Published: (2019-02-01)

Investigation of Growth of Campylobacter Species From Clinical Specimens and Determination of Their Antimicrobial Susceptibility
by: Recep Borucu, et al.
Published: (2019-01-01)

Anti-<i>Candida albicans</i> Activity of Thiazolylhydrazone Derivatives in Invertebrate and Murine Models
by: Lana Ivone Barreto Cruz, et al.
Published: (2018-12-01)

<i>Candida auris</i>: An Overview of How to Screen, Detect, Test and Control This Emerging Pathogen
by: Teresa Fasciana, et al.
Published: (2020-11-01)

Antimicrobial Photodynamic Therapy in Combination with Nystatin in the Treatment of Experimental Oral Candidiasis Induced by <i>Candida albicans</i> Resistant to Fluconazole
by: Karem Janeth Rimachi Hidalgo, et al.
Published: (2019-09-01)

Antifungal Siderophore Conjugates for Theranostic Applications in Invasive Pulmonary Aspergillosis Using Low-Molecular TAFC Scaffolds
by: Joachim Pfister, et al.
Published: (2021-07-01)

Biomaterials for the Prevention of Oral Candidiasis Development
by: Dan Cristian Gheorghe, et al.
Published: (2021-05-01)

Discordance of vancomycin minimum inhibitory concentration for methicillin-resistant Staphylococcus aureus at 2 μg/mL between Vitek II, E-test, and Broth Microdilution
by: Chien-Feng Kuo, et al.
Published: (2020-05-01)

Combination of Posaconazole and Amphotericin B in the Treatment of <i>Candida glabrata</i> Biofilms
by: Célia F. Rodrigues, et al.
Published: (2018-12-01)

Coccidioidomycosis: Changing Concepts and Knowledge Gaps
by: Neil M. Ampel
Published: (2020-12-01)